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a b s t r a c t 
Stable and soluble proteins are ideal candidates for functional and structural studies. Unfortunately,
some proteins or enzymes can be difﬁcult to isolate, being sometimes poorly expressed in heterologous
systems, insoluble and / or unstable. Numerous methods have been developed to address these issues,
from the screening of various expression systems to the modiﬁcation of the target protein itself. Here
we use a hydrophobic, aggregation-prone, phosphate-binding protein (HPBP) as a case study. We de-
scribe a simple and fast method that selectively uses ancestral mutations to generate a soluble, stable
and functional variant of the target protein, here named sHPBP. This variant is highly expressed in Es-
cherichia coli , is easily puriﬁed and its structure was solved at much higher resolution than its wild-type
progenitor (1.3 versus 1.9 A˚, respectively). 
C © 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical
Societies. All rights reserved.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Introduction 
Stable, soluble and functional proteins comprise ideal models for
functional and structural studies. However, when overexpressed in
heterologous systems such as in Escherichia coli , natural proteins from
various sources can sometimes be insoluble, unstable or poorly ex-
pressed [ 1 ]. These difﬁculties considerably hamper studies of certain
proteins, and have yielded a considerable bias in protein functional
and structural analysis toward soluble and expressible proteins [ 2 ].
Several strategies have been developed to skirt these limitations. Clas-
sical methods involving expression in heterologous systems usually
screen the host nature, the culture conditions, and media composition
[ 1 , 3 –5 ]. Codon optimization, protein fusion or the co-expression with
chaperones [ 6 ] may also represent useful strategies to successfully
express proteins [ 1 , 5 , 6 ]. Nevertheless, these trials may remain inefﬁ-
cient in some cases; particularly for numerous mammalian proteins
[ 1 ]. Thus, methodologies tuning the protein target itself emerged, This is an open-access article distributed under the terms of the Creative Commons 
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http://dx.doi.org/10.1016/j.fob.2013.12.006 with the aim of producing soluble and expressible models for fur-
ther studies [ 7 , 8 ]. In that respect, site-directed mutagenesis could
be used to substitute surface residues and therefore generate more
soluble proteins. However, this technique is limited by our ability
to precisely identify problematic surface residues [ 9 ]. Conversely, di-
rected evolution allows to extensively mutate the target protein and
to select for more soluble variants [ 10 ]. The explored sequence space
is however huge, and the method thus requires a high throughput
screening method [ 11 ]. An alternative method, called DNA shufﬂing,
uses several genes sharing high sequence identity with the target pro-
tein and shufﬂes them all. The screening of the resulting gene library
for solubility may yield soluble and expressible variants, which can
subsequently be subjected to functional and structural studies [ 7 ]. 
In regard to protein stabilization or solubilization, phylogenetic-
based protein engineering may represent a powerful method. Indeed,
consensus libraries, which are composed of mutations that bring the
sequence of the target gene closer to the family consensus sequence,
can efﬁciently stabilize proteins [ 12 ]. Ancestral mutations also have
proven ability to yield soluble and stabilized protein variants [ 13 , 14 ].
Moreover, the use of ancestral mutations libraries can yield interest-
ing protein variants with altered enzymatic activity and / or stability
[ 11 , 15 –18 ]. Ancestral mutations may therefore be turned into an easy
and fast method to solubilize / stabilize contemporary proteins. 
In this study, we focus on ancestral mutations, and their ability to
solubilize a protein target. We therefore used the human phosphate
binding protein (HPBP) as a case study. HPBP belongs to DING proteinsf European Biochemical Societies. All rights reserved. 
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 amily, a clade of the phosphate binding protein (PBP) superfamily 
 19 ]. HPBP is a hydrophobic, possibly an apolipoprotein, crystallized 
rom supposedly pure human paraoxonase (PON1) preparations [ 20 –
2 ]. HPBP possesses a venus-ﬂytrap topology identical to the high 
fﬁnity phosphate-binding protein (PBP or PstS) carriers of the ABC 
ransporter systems, and a similar phosphate-binding ability [ 22 ]. In- 
erestingly, and as for other related DING proteins [ 23 –25 ], HPBP has 
een shown to inhibit HIV-1 replication by targeting the transcrip- 
ional step [ 26 ]. 
Nevertheless, functional and structural studies on HPBP are con- 
iderably hampered by its high hydrophobicity [ 22 ], its propensity to 
ggregate, and the failure to express it heterologously in soluble form 
Chabriere, unpublished results). The existing puriﬁcation procedure, 
tarting from human plasma samples, is complex and laborious, and 
ields to little amounts of pure HPBP [ 20 ]. We hereby describe a sim- 
le and fast method to generate an ancestral-mutations based, fully 
unctional, soluble variant of HPBP. 
aterials and methods 
hylogenetic analysis and ancestral resurrection 
The sequences of phosphate-binding proteins (including DING and 
stS proteins) were collected from the National Center of Biotech- 
ology Information (NCBI) using protein alignment BLAST (blastp) 
 27 , 28 ] with default parameters versus the non-redundant protein 
equence database (nr). Only complete protein sequences were se- 
ected, and redundancy was subsequently removed (maximum 95% of 
equence identity) with Cd-hit [ 29 ]. The sequence alignment was per- 
ormed with clustalW 2.0 software [ 30 ] and manually improved ( Fig. 
 -1). The substitution matrix corresponding to the sequence align- 
ent was determined using the Prottest software [ 31 ]. The align- 
ent was subsequently submitted to PhyML software [ 32 ] with the 
TT substitution matrix with 100 iterations. The prediction of the puta- 
ive ancestral sequences at each nodes was performed using FastML 
 33 ]. We have chosen the putative ancestor of HPBP and a related, 
acterial, soluble homologue, PﬂuDING from Pseudomonas ﬂuorescens 
Node 10) ( Fig. 1 -2) [ 34 , 35 ]. The ancestral mutation library contains 
he substitutions of the putative ancestral sequence, as compared to 
PBP sequence. By applying four simple ﬁlters: 
(1) include substitutions of surface apolar residue into polar 
residue, 
(2) include substitution from Gly to X, with the exception of Gly 
residue involved in the start / end of secondary structure, 
(3) include core mutations, 
(4) include mutations that change a surface hydrophobic residue 
into a less hydrophobic one, we have reduced the numbers of 
substitutions from 93 to 22 ( Fig. 1 -3). 
ene synthesis and cloning of HPBP and sHPBP 
The genes encoding for HPBP and sHPBP were optimized for E. coli 
xpression and synthesized by service providers (Genecust, Luxem- 
ourg, and GeneArt, Life Technologies, France, respectively) ( Fig. 1 -4). 
he genes were subsequently subcloned into pET22b ( + ) (Novagen) 
sing Nco I and Xho I as cloning sites. 
roduction and puriﬁcation of HPBP and sHPBP 
Productions of HPBP and sHPBP were performed using E. coli 
L21(DE3)-pGro7 / GroEL cells (TaKaRa) in 6 l of ZYP medium [ 1 ] 
100 μg ml −1 ampicillin, 34 μg ml −1 chloramphenicol). The cultures 
ere grown at 37 ◦C to reach OD 600nm = 0.6 and then induced by 
tarting the consumption of lactose in ZYP medium coupled to tem- 
erature transition to 17 ◦C during 16 h. Cells were harvested by centrifugation (4500 g , 4 ◦C, 15 min) and pellets were suspended in 
400 ml of lysis buffer (20 mM TRIS, pH 8, 100 mM NaCl, Lysozyme 
0.25 mg ml −1 , DNAse I 10 μg ml −1 , PMSF 0.1 mM, MgSO 4 20 mM and 
8 tablets of anti-protease EDTA-free (Roche)) and stored at −80 ◦C for 
2 h. Cells were then thawed at 37 ◦C for 15 min and disrupted by 3 
steps of 30 s of sonication (QSonica sonicator; amplitude 40). Debris 
was removed by centrifugation (12,500 g , 4 ◦C, 30 min). Supernatant 
was loaded on a Nickel afﬁnity column (HisTrap 5 ml, FFCrude from 
GE Healthcare) at a ﬂow rate of 5 ml min −1 . Proteins gripped to the 
column were eluted by imidazol, using an elution buffer (20 mM TRIS, 
pH 8, 100 mM NaCl and 250 mM imidazole). Then, a size exclusion 
chromatography step (Superdex 75 16 / 60, GE Healthcare) was per- 
formed using buffer 20 mM TRIS, pH 8 and 100 mM NaCl. Protein 
production and purity were checked by 15% SDS–PAGE analysis ( Fig. 
1 -5) and mass spectrometry analysis (Plateforme Timone, Marseille, 
France). 
Crystallization of sHPBP 
sHPBP was concentrated to 4 mg ml −1 using a centrifugation de- 
vice (Vivaspin 500, MWCO 3 kDa, Sartorius stedim, Germany). Crys- 
tallization trials were performed at 298 K using the same condition 
as the homologue PﬂuDING ( i.e. LiSO 4 1 M, 20–30% PEG 8000 and 
Sodium Acetate 2 M at pH 4.5–5.5, [ 34 , 36 , 37 ]). Since only thin crys-
tal plates were obtained, commercial screens conditions were tested 
( i.e. Stura and MDL, Molecular Dimension, England) using a Mosquito 
instrument (TTP Labtech, England) with the sitting-drop vapor diffu- 
sion method setup in a 96-well plate. Drops were monitored using 
a Discovery V8 binocular microscope and an AxioCam ERc5S camera 
(Zeiss, Germany). Crystals were obtained in the MDL screen, in a con- 
dition containing 0.2 M Sodium Acetate, 0.1 M Sodium Cacodylate 
pH 6.5 and 25% PEG 8000, and using a 2:1 (protein:reservoir) ratio 
(200 nl:100 nl). In order to obtain bigger crystals, this condition was 
optimized using the hanging drop method. The ﬁnal condition (0.2 
M Sodium Acetate, 0.1 M Sodium Cacodylate pH 6.5 and 25% PEG 
8000), and using a 2:1 (protein:precipitant) ratio (500 nl:250 nl), led 
to the apparition of three-dimensional crystals (around 75–100 μm). 
Reproducible crystals appeared after 3 days at 298 K. 
Data collection and structure resolution of sHPBP 
The crystal was transferred few seconds in a drop (1 μl) contain- 
ing a cryo-protectant solution made out of the mother liquor plus 10% 
(v / v) of glycerol. After mounting on a CryoLoop (Hampton research), 
crystal was ﬂash-frozen in liquid nitrogen. X-ray diffraction intensi- 
ties were collected on the ID23-1 beamline at the ESRF (Grenoble, 
France) using a wavelength of 0.97655 A˚ and a Pilatus 6M detector 
with 0.15 s exposures. Diffraction data were collected from 1027 im- 
ages; each frames consisted of 0.15 ◦ step oscillations, over a range of 
154.05 ◦ ( Table 1 ). The molecular replacement using the HPBP struc- 
ture as model (PDB: 2V3Q ) was performed with Phaser [ 38 ]. The so- 
lution was then used for reﬁnement performed using REFMAC5 and 
phenix [ 39 , 40 ], the model was improved using Coot [ 41 ]. The model 
and structure factor were deposited under the Protein Data Bank code 
PDB: 4M1V ( Table 1 ). 
HIV inhibition by HPBP and sHPBP 
Inhibition assays were performed in HeLa cells, as previously de- 
scribed [ 23 ]. Brieﬂy, HeLa cells were maintained in DMEM + 10 % 
FBS with antibiotics (100 U / ml of Penicillin and 100 mg / ml of Strep- 
tomycin). Cells were pre-incubated with proteins (0.25 μg / ml) for 
48 h, then transfected using Lipofectamine 2000 transfection reagent 
with 0.5 μg of HIV-LTR-luciferase reporter plasmid. Each transfection 
was done in triplicate. 
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Fig. 1. Selective use of ancestral mutations for protein solubilization. (1) Orthologous and paralogous protein sequences of the target protein has been identiﬁed and aligned. (2) 
A phylogenetic tree was constructed using this alignment, and the most probable ancestral sequence at each node were inferred. The substitutions between the most probable 
ancestral sequence at a given node and the contemporary target protein sequence ( i.e wt HPBP) delineate the ancestral library. (3) Using a structural model and simple criteria (see 
methods), ancestral positions were ﬁltered. (4) The gene coding for the ancestral variant was synthetized and (5) the protein was expressed, puriﬁed and crystallized. 
Table 1 
Data collection and reﬁnement statistics of sHPBP structure. 
Data collection 
Dataset Native 
PDB ID 4M1V 
Beamline ID23-1 
Wavelength ( ˚A) 0.97655 
Detector PILATUS 6M 
Oscillation ( ◦) 0.15 
Number of frames 1027 
Resolution ( ˚A) (last bin) 1.3 (1.4–1.3) 
Space group C2 
Unit-cell parameters ( ˚A) a = 125.04, b = 71.99, c = 38.98, β = 
103.12 
No. of observed reﬂections (last bin) 268471 (52411) 
No. of unique reﬂections (last bin) 81625 (16226) 
Completeness (%)(last bin) 98.8 (99.3) 
R meas (%) (last bin) 4.1 (27.5) 
CC (1 / 2) (last bin) 99.9 (95.3) 
I /σ ( I ) (last bin) 21.36 (4.65) 
Redundancy (last bin) 3.28 (3.23) 
Reﬁnement statistics 
R free / R work 13.96 / 10.47 
No. of total model atoms 3541 
Ramachandran favored (%) 98.4 
Ramachandran outliers (%) 0 
Generously allowed rotamers (%) 1.6 
Rmsd from ideal 
Bond lengths ( ˚A) 0.027 
Bond angles ( ◦) 2.466 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Results 
Ancestral mutations as a tool for protein solubilization 
A phylogenetic tree of the PBPs, including DING proteins was gen-
erated ( Figs. 1 and 2 A), and the most probable ancestral sequence
at Node 10 was reconstructed ( Fig. 2 A, see methods). The sequence
of this putative ancestor exhibits 93 substitutions with the contem-
porary HPBP sequence ( Fig. 2 B). Among them, 22 substitutions were
rationally selected ( Fig. 2 B and C). The selection was made using very
simple criteria, such as (i) include substitutions of surface apolar /
hydrophobic residues into polar / less hydrophobic ones, (ii) include
core mutations, and (iii) include substitutions of glycine to X, when
the glycine residue is not involved in the start / end of a secondary
structure (see methods). The selected substitutions are in fact mainly
located at the protein surface ( Fig. 2 D), and are predicted to solubilize
the target protein, as shown by the hydrophobic proﬁle comparison
of sHPBP and HPBP ( Fig. 3 ). 
The gene coding for sHPBP, the ancestral variant that includes 22
substitutions, was synthetized, and both sHPBP and wt HPBP were
heterologously expressed in E. coli strain BL21(DE3)-pGro7 / EL, using
the same protocol. Protein expression proﬁles show that wt HPBP is
expressed in E. coli , albeit solely in the insoluble fraction ( Fig. 4 , left
part). Conversely, sHPBP is largely present in the soluble fraction ( Fig.
4 , middle part). Noteworthy, both proteins share more than 94% of
sequence identity but possess opposite solubility proﬁles in E. coli .
The expression of sHPBP is signiﬁcant, as illustrated by the puriﬁca-
tion yield: about 12 mg of pure protein per liter of culture ( Fig. 4 ,
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Fig. 2. Phylogeny of PBPs and selected ancestral mutations. (A) Phylogenetic tree of PBPs, including PstS proteins (in pink) and DING proteins (in blue). Bootstrap values are shown 
for each node. (B) Sequence alignment of the target protein sequence ( wt HPBP), the most probable ancestor sequence (Node 10) and the ancestral variant sequence containing 
selected substitutions (sHPBP). (C) Ancestral substitutions that were retained after structure-based ﬁltering: substitutions changing apolar residues into polar residues (orange), 
hydrophobic residues into less hydrophobic ones (magenta), core substitutions (cyan) and D192Q substitution (purple) are listed. Secondary structures are represented in gray 
and light brown, for α-helix and β-sheet, respectively. (D) Retained ancestral substitutions locations on sHPBP structure are colored as in (C). The protein surface is represented 
as transparent gray and the bound phosphate anion is shown as red spheres. (For interpretation of the references to colour in this ﬁgure legend, the reader is reffered to the web 
version of this article.) 
Daniel Gonzalez et al. / FEBS Open Bio 4 (2014) 121–127 125 
Fig. 3. Hydropathy proﬁle discrepancy between sHPBP and HPBP. The hydropathy 
proﬁles of both proteins were determined using the software “ProtScale” in Expasy 
website (algorithm Kyte and Doolitle, Window size 5). The graph represents, in y-axis, 
the difference of the hydrophobic potential between sHPBP and HPBP along the protein 
sequence (in x -axis). The light blue bars are for the sequence regions where sHPBP is 
predicted to be the more hydrophilic than HPBP, whereas regions where sHPBP is 
predicted to be more hydrophobic are shown as pink bars. (For interpretation of the 
references to colour in this ﬁgure legend, the reader is reffered to the web version of 
this article.) 
Fig. 4. Solubility of wt HPBP and sHPBP when overexpressed in E. coli . The left part, 
middle part and left part of this Coomassie-stained SDS–PAGE gel correspond to the 
expression of HPBP, the expression of sHPBP, and the puriﬁed sHPBP, respectively. 
The lanes “P” and “SN” are for pellet and supernatant, respectively. Molecular weight 
markers (lane “Mw”) are indicated in kiloDalton (kDa; Spectra Multicolor broad range 
protein ladder). Arrows indicate the expected position of HPBP and sHPBP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 right part). Additionally, whereas HPBP is aggregation-prone, sHPBP
is soluble, including in the absence of detergent, and present a melting
temperature ( T m ) of 47.2 ± 0.13 ◦C. 
sHPBP and wt HPBP share nearly identical structures 
sHPBP yielded high quality crystals and its structure was solved at
1.3 A˚ resolution ( Table 1 ), a resolution that is higher than the previ-
ous structure of HPBP (1.9 A˚) [ 42 ]. As expected by the high sequence
identity between both proteins (94% identity), the structure of sHPBP
is extremely similar to that of HPBP. The structures of both proteins
exhibit identical topology, where the two globular domains are linked
together by a ﬂexible hinge. Each domain is composed of a central core
β-sheets which is ﬂanked by α-helix and present at their interface
the phosphate binding cleft. Both structures superimpose extremely
well, with a RMSD on all carbon α positions of 0.2 A˚ ( Fig. 5 A), in-
cluding in the phosphate binding cleft region ( Fig. 5 B). Nonetheless,
small differences relate to slightly different conformations of the 4
protuberant surface loops, some being possibly affected by ancestral
mutations. The crystal packings of HPBP and sHPBP being different,
we cannot exclude that packings affected the conformations of thesesurface loops. Interestingly, the calculation of the surface electrostatic
potential of both structures reveals signiﬁcantly different patterns,
consistent with a superior solubility of sHPBP, since the apolar (or
hydrophobic) surface patches present in HPBP structure are smaller
in the sHPBP structure ( Fig. 5 C). 
The soluble variant sHPBP is functional 
Besides the phosphate binding ability, HPBP has been shown to ex-
hibit anti-HIV-1 properties [ 26 ]. The anti-HIV properties of HPBP and
sHPBP have thus been compared using a LTR-reporter system in HeLa
cells. Each assay was performed by pre-incubation of proteins at the
estimated IC 50 value of HPBP ( i.e. 5 nM), previously determined us-
ing derived-immune system cells (Peripheral blood lymphocytes and
primary macrophages) [ 26 ]. At this concentration and on HeLa cells,
HPBP has a strong inhibitory effect on the HIV transcription (78%).
We here show that sHPBP inhibits the HIV transcription with a very
similar efﬁciency (68%) ( Fig. 5 D). This strongly suggests that sHPBP
shares similar inhibition properties ( e.g . IC 50 , CC 50 ) and mechanisms
than wt HPBP. 
Discussion 
Ancestral variants such as sHPBP comprise excellent model for 
functional studies of poorly soluble proteins 
HPBP is a protein with an increasing interest because of its HIV-
1 inhibition properties. However, its study has long been hampered
because of its intrinsic hydrophobic character, and the resulting dif-
ﬁculty to obtain and store puriﬁed protein. We used ancestral mu-
tations to generate a soluble variant of HPBP. This variant, sHPBP,
can be expressed and puriﬁed from a convenient host, E. coli , with a
signiﬁcant puriﬁcation yield ( ∼12 mg / l of culture), whereas this clas-
sical approach failed with wt HPBP. The enhanced expression level
observed for sHPBP is concomitant to its higher solubility, compared
to the wt protein. This dramatic change in behavior may be mainly as-
cribed to the decrease of the protein’s surface hydrophobicity. sHPBP
is therefore a more convenient protein to work with, and a critical
consequence of this fact resides in the obtaining of sHPBP structure
at 1.3 A˚ resolution; whereas HPBP structure was solved at 1.9 A˚. In-
deed, a better control on the puriﬁcation process and the availability
of high amounts of puriﬁed protein are key factors for optimization
of crystallization conditions. 
The structure of sHPBP reveals that it is extremely similar to that
of wt HPBP. Most importantly, the phosphate binding cleft of both
proteins is nearly identical. Consequently to this high similarity, sH-
PBP shares a similar HIV-1 inhibition capacity with wt HPBP. sH-
PBP therefore represents an excellent model for future structural and
functional studies, with the aim of deciphering the biological func-
tion(s) of HPBP. 
A fast, easy and efﬁcient method based on ancestral mutations can 
produce soluble variants 
We describe here the construction of a soluble variant of the hy-
drophobic, aggregation-prone, HPBP using ancestral mutations. The
employed methodology is fast, simple and yielded a variant that is
both soluble and active. Ancestral mutations and libraries indeed
comprise an efﬁcient tool for focusing substitutions to positions that
can readily promote changes in protein stability, solubility or even
substrate speciﬁcity [ 11 , 13 , 43 ]. A primordial property of ancestral
mutations resides in the possibility of incorporating a very large num-
ber of these mutations, while maintaining the produced variants vi-
able [ 11 , 43 ]. Therefore, by properly choosing ancestral mutations ( e.g.
active site substitutions), one can efﬁciently alter the substrate speci-
ﬁcity of enzymes [ 11 ]. 
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Fig. 5. Structural and functional comparison of sHPBP and wt HPBP. (A) Structural superposition of sHPBP (yellow) and wt HPBP (blue). Phosphate is represented as red spheres. 
(B) Superposition of the phosphate binding cleft of both proteins (sHPBP (yellow) and HPBP (blue)). (C) Electrostatic potential comparison of both proteins. Positive and negative 
charges are respectively represented in red and blue. White regions are neutrally charged or hydrophobic. (D) Inhibition of the HIV-1 transcription, measured using a LTR-luciferase 
reporter system in HeLa cells. The constitutive luminescence of the system is represented in HIV-1 LTR (gray). The inhibition properties of the different samples (0.25 μg / ml) are 
shown: Bovine Serum Albumin (green), wt HPBP (blue) and sHPBP (yellow). (For interpretation of the references to colour in this ﬁgure legend, the reader is reffered to the web 
version of this article.) 
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tHere, we chose ancestral node 10 that relates the hydrophobic 
PBP to a bacterial homologue dubbed PﬂuDING, reported to be a 
oluble and stable protein [ 34 ]. Then, among the substitutions be- 
ween the putative ancestors and the HPBP sequence, we have mainly 
etained surface residues that may have a stabilizing and / or a solubi- 
izing effect by applying 4 simple criteria (see Results). The resulting 
equence was subsequently synthetized and yielded a soluble vari- 
nt, sHPBP. The requirements for this method are limited to a good 
equence sampling of the protein family, as well as a structure model 
or proper selection of the inferred ancestral mutations. This method 
an therefore be applied in numerous cases. 
We believe that the selective use of ancestral mutations described 
ere complements the existing approaches for producing more sta- 
le proteins, such as directed evolution, family shufﬂing, consensus 
ibraries and others. However, its unique feature and its simplicity 
ake it attractive to use with challenging protein targets, with the 
im of producing, stable, soluble variants with increased propensity 
o crystallize. 
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